These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 17178855)

  • 21. High mobility group A: a novel biomarker and therapeutic target in pancreatic adenocarcinoma.
    Liau SS; Whang E
    Surgeon; 2009 Oct; 7(5):297-306. PubMed ID: 19848064
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TGF-β1 induces HMGA1 expression: The role of HMGA1 in thyroid cancer proliferation and invasion.
    Zhong J; Liu C; Zhang QH; Chen L; Shen YY; Chen YJ; Zeng X; Zu XY; Cao RX
    Int J Oncol; 2017 May; 50(5):1567-1578. PubMed ID: 28393241
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gli1 contributes to the invasiveness of pancreatic cancer through matrix metalloproteinase-9 activation.
    Nagai S; Nakamura M; Yanai K; Wada J; Akiyoshi T; Nakashima H; Ohuchida K; Sato N; Tanaka M; Katano M
    Cancer Sci; 2008 Jul; 99(7):1377-84. PubMed ID: 18410405
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High mobility group protein HMGA1 inhibits retinoblastoma protein-mediated cellular G0 arrest.
    Ueda Y; Watanabe S; Tei S; Saitoh N; Kuratsu J; Nakao M
    Cancer Sci; 2007 Dec; 98(12):1893-901. PubMed ID: 17877762
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TIMP-1 antisense gene transfection attenuates the invasive potential of pancreatic cancer cells in vitro and inhibits tumor growth in vivo.
    Bloomston M; Shafii A; Zervos E; Rosemurgy AS
    Am J Surg; 2005 Jun; 189(6):675-9. PubMed ID: 15910719
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Specific interference of urokinase-type plasminogen activator receptor and matrix metalloproteinase-9 gene expression induced by double-stranded RNA results in decreased invasion, tumor growth, and angiogenesis in gliomas.
    Lakka SS; Gondi CS; Dinh DH; Olivero WC; Gujrati M; Rao VH; Sioka C; Rao JS
    J Biol Chem; 2005 Jun; 280(23):21882-92. PubMed ID: 15824107
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A study of the suppressive effect on human pancreatic adenocarcinoma cell proliferation and angiogenesis by stable plasmid-based siRNA silencing of c-Src gene expression.
    Zhao X; Li DC; Zhao H; Li Z; Wang JX; Zhu DM; Zhou J; Cen JN
    Oncol Rep; 2012 Mar; 27(3):628-36. PubMed ID: 22200682
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of miR‑26a exhibits a negative correlation with HMGA1 and regulates cancer progression by targeting HMGA1 in lung adenocarcinoma cells.
    Sekimoto N; Suzuki A; Suzuki Y; Sugano S
    Mol Med Rep; 2017 Feb; 15(2):534-542. PubMed ID: 28000891
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of PI3K/AKT pathway in gastric cancer and its blockade suppresses tumor growth and metastasis.
    Ye B; Jiang LL; Xu HT; Zhou DW; Li ZS
    Int J Immunopathol Pharmacol; 2012; 25(3):627-36. PubMed ID: 23058013
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overexpression of HMGA1 deregulates tumor growth via cdc25A and alters migration/invasion through a cdc25A-independent pathway in medulloblastoma.
    Lau KM; Chan QK; Pang JC; Ma FM; Li KK; Yeung WW; Cheng AS; Feng H; Chung NY; Li HM; Zhou L; Wang Y; Mao Y; Ng HK
    Acta Neuropathol; 2012 Apr; 123(4):553-71. PubMed ID: 22249617
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HMGA1 participates in MHCC97H cell proliferation and invasion through the ILK/Akt/GSK3β signaling pathway.
    Liu L; Zhang S; Hu L; Liu L; Guo W; Zhang J
    Mol Med Rep; 2017 Dec; 16(6):9287-9294. PubMed ID: 29152644
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Silencing of HMGA1 expression by RNA interference suppresses growth of osteogenic sarcoma.
    Yuan S; Pan Q; Fu C; Bi Z
    Mol Cell Biochem; 2011 Sep; 355(1-2):281-7. PubMed ID: 21573994
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CEACAM6 gene silencing impairs anoikis resistance and in vivo metastatic ability of pancreatic adenocarcinoma cells.
    Duxbury MS; Ito H; Zinner MJ; Ashley SW; Whang EE
    Oncogene; 2004 Jan; 23(2):465-73. PubMed ID: 14724575
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhanced tumor growth and invasiveness in vivo by a carboxyl-terminal fragment of alpha1-proteinase inhibitor generated by matrix metalloproteinases: a possible modulatory role in natural killer cytotoxicity.
    Kataoka H; Uchino H; Iwamura T; Seiki M; Nabeshima K; Koono M
    Am J Pathol; 1999 Feb; 154(2):457-68. PubMed ID: 10027404
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hmga1 is differentially expressed and mediates silencing of the CD4/CD8 loci in T cell lineages and leukemic cells.
    Xi Y; Watanabe S; Hino Y; Sakamoto C; Nakatsu Y; Okada S; Nakao M
    Cancer Sci; 2012 Mar; 103(3):439-47. PubMed ID: 22106824
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aberrant expression of PDZ-binding kinase/T-LAK cell-originated protein kinase modulates the invasive ability of human pancreatic cancer cells via the stabilization of oncoprotein c-MYC.
    Hinzman CP; Aljehane L; Brown-Clay JD; Kallakury B; Sonahara F; Goel A; Trevino J; Banerjee PP
    Carcinogenesis; 2018 Dec; 39(12):1548-1559. PubMed ID: 30165468
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HMGA1 promotes breast cancer angiogenesis supporting the stability, nuclear localization and transcriptional activity of FOXM1.
    Zanin R; Pegoraro S; Ros G; Ciani Y; Piazza S; Bossi F; Bulla R; Zennaro C; Tonon F; Lazarevic D; Stupka E; Sgarra R; Manfioletti G
    J Exp Clin Cancer Res; 2019 Jul; 38(1):313. PubMed ID: 31311575
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The high-mobility group A1a/signal transducer and activator of transcription-3 axis: an achilles heel for hematopoietic malignancies?
    Hillion J; Dhara S; Sumter TF; Mukherjee M; Di Cello F; Belton A; Turkson J; Jaganathan S; Cheng L; Ye Z; Jove R; Aplan P; Lin YW; Wertzler K; Reeves R; Elbahlouh O; Kowalski J; Bhattacharya R; Resar LM
    Cancer Res; 2008 Dec; 68(24):10121-7. PubMed ID: 19074878
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CCN3 increases cell motility and MMP-13 expression in human chondrosarcoma through integrin-dependent pathway.
    Tzeng HE; Chen JC; Tsai CH; Kuo CC; Hsu HC; Hwang WL; Fong YC; Tang CH
    J Cell Physiol; 2011 Dec; 226(12):3181-9. PubMed ID: 21344378
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapy of human pancreatic carcinoma based on suppression of HMGA1 protein synthesis in preclinical models.
    Trapasso F; Sarti M; Cesari R; Yendamuri S; Dumon KR; Aqeilan RI; Pentimalli F; Infante L; Alder H; Abe N; Watanabe T; Viglietto G; Croce CM; Fusco A
    Cancer Gene Ther; 2004 Sep; 11(9):633-41. PubMed ID: 15272314
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.